Determining the contribution of functional genetic categories is fundamental to understanding the 2 genetic etiology of complex human traits and diseases. Here we present Annotation Informed MiXeR: a 3 likelihood-based method to estimate the number of variants influencing a phenotype and their effect 4 sizes across different functional annotation categories of the genome using summary statistics from 5 genome-wide association studies. Applying the model to 11 complex phenotypes suggests diverse 6 patterns of functional category-specific genetic architectures across human diseases and traits. 7 8 Keywords: genetic architecture, complex traits, functional genetic categories, polygenicity, variant effect 9 size 10 11 Background 12 The rapid technological advances of the last years have provided an enormous amount of genetic data 13 thereby promoting the development of statistical methods aimed to unravel the genetic architecture of 14 complex traits [1]. A key effort has been to estimate SNP-based heritability, either using individual-level 15 genotype data [2], or summary-level statistics from genome-wide association studies (GWAS) [3]. 16 However, heritability estimates provide a limited picture of the genetic architecture underlying complex 17 phenotypes. For example, they are agnostic about the number of genetic variants influencing a 18 phenotype and their effect sizes [4]. Both of these quantities can vary and still result in the same 19
enriched across functional genomic categories and complex phenotypes [7, 8] . Here we present a 1 model, Annotation Informed (AI) MiXeR, which extends our previous work by allowing different (non-2 overlapping) predefined functional annotation categories of the genome to have various densities of 3 non-null variants with different effect size distributions. 4
Several conceptually related methods aiming to characterize the genetic architecture of phenotypes 5 using GWAS summary statistics have recently been developed. The partitioned LD score regression 6 (LDSC) analysis presented by Finucane and colleagues [9] estimates the proportion of SNP-based 7 heritability explained by variants within predefined functional categories but does not estimate the 8 abundance of non-null variants or assess their effect sizes. The RSS-E method [10] only estimates the 9 abundance of non-null variants in different annotation categories, while the distribution of effect sizes 10 of non-null variants is assumed to be the same throughout the genome. Alternatively, the GENESIS 11 model [11] allows several groups of trait-susceptibility variants with different densities and effect size 12 distributions but assumes the non-null variants to be uniformly distributed among the groups and does 13 not support prior group definition (e.g. in terms of functional annotation categories). AI-MiXeR allows 14 simultaneous modeling of abundance and effect size magnitudes of non-null variants in arbitrary 15 predefined functional annotation categories. 16 We extensively tested AI-MiXeR on synthetic GWAS data generated under various setups to establish 17 scenarios where it reconstructs the underlying parameters correctly. We then applied AI-MiXeR to 18 GWAS summary statistics for 11 complex phenotypes representing a range of diverse human traits and 19 diseases. This analysis suggests that both densities and effect sizes of non-null variants can vary 20 considerably in different genomic annotation categories and reveals diverse patterns of genetic 21 architecture in different phenotypes. 22
(including 5' and 3' untranslated regions) of protein coding genes, while the non-exonic category 3 contains all remaining variants. This choice was motivated by previous research showing that protein 4 coding exons (including 5' and 3' untranslated regions) are most strongly enriched of association with 5 many complex human phenotypes [8] . Additionally, the exonic category, as defined above, largely 6 overlaps with the genomic regions investigated in whole exome genotyping and whole exome 7 sequencing studies. Its modeling can therefore serve as a projection for future discoveries in whole 8 exome studies. All variants were functionally annotated using UCSC's Table Browser (hg19/GRCh37) 9 [15] . With this definition, the non-exonic category contains approximately 70 times more variants than 10 the exonic category. 11
Synthetic phenotypes were generated using SIMU [16] . A given number of non-null variants was selected 12 at random for each functional annotation category. Effect sizes for the selected non-null variants were 13 sampled from the standard normal distribution and then rescaled to obtain the required level of 14 heritability, given different predefined ratios (see below) between the average effect sizes of the two 15 dichotomous functional annotation categories. For each synthetic genotype, a quantitative synthetic 16 phenotype was then generated as the sum of allelic effects over all non-null variants complemented by 17 a certain proportion of a random Gaussian noise (representing effects of the environment) required to 18 keep the predefined level of heritability. Finally, association tests were performed using PLINK 1.9 to 19 obtain GWAS summary statistics. 20
Simulation setup. All possible combinations of the following parameter values were used for generating 21 synthetic phenotypes:
=10 -1 , 10 -2 , 10 -3 ; − =10 -2 , 10 -3 , 10 -4 ; 2 / − 2 =0.1, 1.0, 22 10.0; ℎ 2 =0.1, 0.4, 0.7, resulting in 81 different parameter setups covering a broad range of genetic 23 architectures. Ten different phenotypes with independently generated locations of non-null variants and 24 effect sizes thereof were generated for each combination of parameters, resulting in 810 synthetic 6 The simulations demonstrate that the true parameters are estimated accurately when the proportions 1 of heritability carried by both functional categories are comparable and each category individually 2 carries >2% of the total heritability; if one of the functional categories carries a negligible fraction (<2%) 3 of the total heritability the model often fails to reconstruct its parameters accurately (Supplementary 4 Figure 1 ). Selected simulation cases representing scenarios closely resembling phenotypes analyzed in 5 this study are presented in Figure 1 . These simulations show that in the range of parameters observed 6 (according to the model) in the 11 phenotypes analyzed in this study, the model is able to provide 7 instructive unbiased estimates of and 2 parameters for both exonic and non-exonic functional 8 annotation categories. A complete comparison of true simulation parameters and corresponding model 9 estimates for all 810 simulated phenotypes is shown in Supplementary Figures 2 -4 , and the 10 corresponding numerical results are given in Supplementary Table 3 . Of note is that, in general, 11 heritability estimates are more robust than estimates of and 2 . 12 We applied the model to GWAS summary statistics on 11 phenotypes (Figure 2 , Supplementary Table 1)  2 including schizophrenia (SCZ) [17] , bipolar disorder (BD) [18] , attention deficit/hyperactivity disorder 3 (ADHD) [19] , general cognitive ability (COG) [20] , educational attainment (EA) [21] , type 2 diabetes (T2D) 4 [22] , inflammatory bowel disease (IBD) [23] , low-density lipoproteins (LDL) [24] , body mass index (BMI) 5 [25] , height [25] and waist-hip ratio (WHR) [26] . Details on these studies including year of publication 6 and number of samples (cases/controls when appropriate) are given in Supplementary Table 4 . 7
Like in simulations with synthetic data, we consider here two functional annotation categories for the 8 variants: exonic and non-exonic. For ease of comparison with partitioned LDSC method [9] , the LD 9 structure was estimated with PLINK 1.9 using genotype data from LDSC's template [27] containing 10 9,997,231 biallelic variants for 489 unrelated European individuals (originally derived from 1000 11
Genomes Phase 3 data [13] ). Trans-chromosome correlations as well as correlations between variant 12 genotypes at 2 < 0.05 were disregarded. We also obtained estimates of SNP-heritability per functional 13 category for all 11 phenotypes using partitioned LDSC. These estimates are compared with AI-MiXeR's in 14 Supplementary Table 1 . The polygenicity parameters (πexonic and πnon-exonic) can be 15 converted into the number of non-null variants by multiplying them by the total number of variants 16
within the corresponding annotation category. The numbers ensuing for the analyzed phenotypes are 17 presented in Supplementary Table 1 . For each phenotype, 50 independent optimization runs were 18 performed to maximize the likelihood of the GWAS z-scores observed in different subsets of 10 6 19 randomly selected variants. 20 its very low polygenicity in ADHD and its very low discoverability in WHR). This is reflected in larger error 6 bars for the exonic category in these phenotypes (Figure 2 , Supplementary Table 1 ). However, the 7 observed consistency of parameter estimates across all 50 independent optimization runs for all 8 analyzed phenotypes encourages to draw conclusions about actual features of the underlying genetic 9
architecture.
Discussion

1
We present the AI-MiXeR model, which can be used to decouple and partition a phenotype's heritability 2 into functional category-specific polygenicity (proportion of non-null variants) and discoverability 3 (variance of non-null effect sizes) components and thus better characterize the phenotype's genetic 4 architecture. 5
It is widely assumed that protein coding exons contain a higher proportion of causal variants (higher 6 polygenicity) and have on average stronger effects (higher discoverability) on complex phenotypes when 7 compared to non-exonic regions [8, 28, 29] . In our study, the AI-MiXeR model suggests that less than 8 half (5 of 11) of the analyzed phenotypes (SCZ, BD, COG, LDL and BMI) support this assumption. Four 9 other phenotypes (T2D, IBD, height and WHR) show higher density of non-null variants in exonic regions 10 but stronger average effects in the non-exonic portion of the genome. In the two remaining traits (ADHD 11 and EA), the pattern appears to be reversed, with a higher density of weaker effect variants in non-12 exonic regions. 13 According to the model, EA has the largest number of non-null variants (48000, with only 0.6% of exonic 14 variants) among all analyzed phenotypes, while IBD has the smallest (3000, 91% exonic) ( Supplementary  15   Table 1 ). However, the effects of the non-null variants are on average 5 times stronger in IBD than in EA 16 and result in a larger total heritability for the former (0.25 in IBD vs 0.1 in EA). SCZ and BD show similar 17 polygenicity (34000 and 30000 non-null variants, of which 9% and 10% respectively are exonic) and 18 discoverability (with exonic effects being approximately twice stronger). In contrast, most non-null 19 variants for height and T2D are exonic (62% out of 15500 and 90% out of 9000 respectively) having on 20 average 10-and 3-times weaker effects respectively than non-exonic variants. 21
The model suggests, that despite having similar heritability, phenotypes may differ substantially in 22 polygenicity and discoverability of non-null variants. For example, both AI-MiXeR and partitioned LDSC 23 provide comparable estimates of total and partitioned heritability for LDL and T2D (AI-MiXeR LDL: 24
=0.09; AI-MiXeR T2D: ℎ 2 =0.13, ℎ 2 =0.06) (Figure 2 , Supplementary Table 1, phenotypes differ drastically, with T2D being approximately 5 times more polygenic than LDL and having 1 91% (vs 15% in LDL) of non-null variants within exons. The polygenicity deficit is compensated in LDL 2 with a discoverability 3.5 times larger than in T2D (50 times larger in the exonic category). 3
From our simulation studies on synthetic GWAS, we can infer that the balance of ℎ 2 partition between 4 the functional annotation categories has a strong effect on the model's performance. Extremely small 5 values of polygenicity ( ) or discoverability ( 2 ) in a functional annotation category (relative to the 6 complementary category) result in a heavily unbalanced heritability partition between the categories 7 and can thus lead to substantial errors in the estimates of and 2 for the category with smaller 8 absolute heritability ( Supplementary Figure 1 top and bottom) . Despite this, heritability estimates were 9 generally robust ( Supplementary Figure 1 -4 , Supplementary Table 3 ). 10
Decoupling the heritability of different functional categories into polygenicity and discoverability may 11 facilitate trait-specific experimental designs prioritizing certain genomic regions for detailed 12 investigation. For instance, by looking only at the heritability pertaining exons in T2D (ℎ 2 = 0.06) 13
and LDL (ℎ 2 = 0.09), one could expect the yield of an exome-wide scan for both phenotypes to be 14 comparable. However, AI-MiXeR predicts that the average effect size (square root of discoverability) of 15 exonic non-null variants is approximately 7 times larger in LDL than in T2D. An exome study of the 16 former could be therefore expected to result in a higher yield of statistically significant findings, given a 17 moderately sized sample. This speculation may be indirectly supported by comparing existing exome-18 wide studies of T2D and LDL. One of the largest exome sequencing studies on T2D (20791 cases, 24440 19 controls) published so far identified 15 variants in 7 distinct genomic loci reaching exome-wide 20 significance level [30] . In contrast, an exome-wide association study of serum lipids in a comparable 21 sample (N = 39087) reported 66 exome-wide significant LDL susceptibility variants within 14 loci [31] . AI-22
MiXeR's predictions also suggest, however, that a significant increase in the sample size for T2D will 23 yield more fruitful results than an equivalent sample size increase in LDL, since T2D has substantially 24 larger polygenicity. 25 variants) were not tested. 9
The model underlying AI-MiXeR is sensitive to the LD structure estimates. Ideally, the LD structure 10 should be estimated on the same sample used for association testing. However, this is mostly 11 impractical if not impossible. Here, in the analysis of GWAS summary statistics for 11 phenotypes we 12 estimated the LD structure using the 1000 Genomes Phase 3 genotype panel. Inconsistencies between 13 the LD structure of the samples used for association testing and that of the 1000 Genomes Phase 3 14 panel could skew the model's results. Additionally, roughening the LD structure (e.g. by ignoring all 15 correlations with 2 below a certain threshold) also could result in biased parameter estimates. In our 16 simulations, 2 was estimated from 10,000 synthetic genotypes (randomly sampled from the complete 17 set of 100,000 synthetic genotypes used for association testing) ignoring all correlations with 2 < 0.01. 18
A subset of European ancestry samples from the 1000 Genomes Phase 3 panel (N = 489) was used to 19 estimate LD 2 values for the GWAS data because of the wide availability of these data, ease of 20 comparison with LDSC and the fact that genotypes in majority of analyzed GWAS were imputed using 21 this panel as a reference. The limited size of the 1000 Genomes panel, however, results in relatively low 22 confidence 2 values, especially for weak correlations involving low-frequency variants. To mitigate this 23 issue, we increased the 2 cutoff, disregarding all correlations with 2 <0.05. Nevertheless, consistency 24 between partitioned heritability estimates produced by AI-MiXeR and LDSC (Figure 2, Supplementary  25 Table 2) suggests the absence of the model-specific systematic biases. 26 1 within functional annotation categories and the effect size's independence of allele frequency and LD. It 2 has recently been shown that these simplified assumptions, which have been used implicitly or explicitly 3 in many earlier methods, can lead to substantial biases in heritability estimates [32] . We previously 4 demonstrated [6] that these factors also bias the model's estimates of and 2 when no distinction is 5 made between annotation categories. We did not investigate how disregarding them affect AI-MiXeR's 6 category-specific estimates. These assumptions are likely violated to different degrees in different 7
phenotypes and make the model more suitable for some phenotypes than for others. In the current 8 report, we provide examples of successful applications of AI-MiXeR, but advise prospective users to 9 carefully assess the model's suitability for a given phenotype. 10
It is also important to note that the numbers of non-null variants presented ( Supplementary Table 1)  11 should be taken with a grain of salt because of the model's assumptions and technical simplifications. 12
The observed relative proportions of non-null variants (and their effect sizes) between functional 13 annotation categories within one trait or across different traits might be more reliable indicators of 14 actual genetic architecture features or differences. 15
Conclusions
16
The AI-MiXeR method presented here considers predefined annotation categories allowing both 17 different proportions of non-null variants and different effect size distributions in various functional 18 annotation categories, which is not possible with other methods available to date [9] [10] [11] . The ability to 19 model predefined annotation categories separately allows hypothesis-driven studies of complex 20 phenotypes, which in turn provide a better understanding of the genetic architecture of those complex 21 phenotypes. Our analysis suggests that both the polygenicity and the discoverability in different 22 functional categories vary considerably across human traits and disorders. Knowing such patterns may 23 facilitate trait-specific experimental designs prioritizing specific genomic regions for detailed 24 investigation.
1 AI-MiXeR model 2 Consider a quantitative phenotype standardized to mean 0 and variance 1. Let be a random variable 3 representing a phenotype measurement for an individual in the population (Ε( ) = 0, var( ) = 1). Let 4
be a fixed set of random variables representing genotypes of bi-allelic variants. These 5 are assumed to be centered (Ε( ) = 0) but not scaled (var( ) = 2 (1 − ) = , where is the 6 minor allele frequency of variant j and ℎ is its heterozygosity). We assume an additive genetic model for 7 the phenotype generation: 8
where is a normally distributed error term with mean 0 and variance 2 . ( ) is understood here as 10 the (unknown) effect of variant j as would be obtained from a multiple linear regression of the 11 phenotype on all genotypes in a hypothetical infinite sample. This definition of the effect size ( ) 12 implies that ( ) will reflect only the true causal effect of the j th variant (thus ( ) = 0 if the j th 13 variant is not causal) whenever includes all causal variants for the trait. On the other hand, if any 14 causal variants are missing in the set , ( ) will also include the effects of those missing causal 15 variants that happen to be tagged by the j th variant. Any variant j with ( ) ≠ 0 will be called a non-16 null variant. Further, we will henceforth consider to be fixed and omit it from the notation. 17
Consider now a GWAS on a quantitative phenotype. Let be the number of individuals in the GWAS 18 and assume that is sufficiently large, so that the allelic composition (i.e. genotype frequencies) of the 19 variants observed in the GWAS is approximately equivalent to the allelic composition of the same 20 variants in the population. Then ̂= (̂1 …̂) is a vector of phenotypes, ̂= [̂] =1… , =1… is the which is a sample-equivalent of (1). Denote also with ̂= (̂1 …̂) the vector of genotypes of 1 By construction (equation (1)), when there is no genetic effect on the phenotype, 2 = 1. However, the 7 assumption of independence of all ̂ is often violated in GWAS due to the presence of various 8 confounding factors such as population stratification and cryptic relatedness. Moreover, both ̂ and ̂ 9 are usually estimated from external genotyping panels where variant frequencies and correlations may 10 differ from those in the GWAS sample. In addition, due to technical limitations, ̂ estimates are 11 commonly truncated (e.g. disregarding all correlations below a certain threshold). For the model to be 12 able to mitigate these discrepancies we introduce a 0 2 parameter and model ̂′ in (5) as a random 13 variable distributed as (0, 0 2 ). It was shown that, in the framework of the infinitesimal model, 0 2 has 14 the same mathematical meaning as the intercept term in the LDSC model [6] . The last unknown factor in 15 (5) , , is modeled as a random variable with point-normal mixture distribution, where the variance is 16 allowed to differ between different variant annotation categories: 17
where variant ∈ , ⊆ is a subset of variants in constituting some annotation category, is the 19 proportion of variants with non-zero effect (non-null variants) in the annotation category and 2 is 20 the variance of the effect sizes among all non-null variants in . The set of annotation categories 1 derive the probability density function of ( ) as the convolution of ( = 1 … ) and ̂′ random 2 variables. 3 4 We derive the probability density function (pdf) of a random variable representing a variant's 5 association z-score from the convolution of ( = 1 … ) and ̂′ random variables. To simplify 6 notation, we omit the indices reflecting the annotation category, replace ̂′ with and denote: 7
Estimation of probability density function of z-scores
where , 2 = 2 2 , ~(0, 0 2 ). We can then rewrite (5) as: 9
= + ∑ =1 10
The probability density function of at 0 (in our case 0 is the z-score from the GWAS) can be written 11 as the inverse Fourier transform of its characteristic function ( ): 12 The result is a definite integral (i.e. a number), which can be computed numerically. 5
Optimization setup 6 The polygenicity ( ) and discoverability ( 2 ) parameters are estimated by maximizing the likelihood of 7 the z-scores observed in the GWAS summary-level data ( 0 ):
, 2 , 0 2 → , where the 8 probability density function of the z-scores ( ) is modeled as described in the section above. Specific 9 estimation details are given below. 10
The following optimization setup was used: 11
• Nelder-Mead method (maxiter=1200, fatol=1e-7, xatol=1e-4, adaptive=True) was applied 12 starting from the best point obtained after a single iteration of differential evolution (maxiter=1, 13 popsize=50, init=latinhypercube, bounds: =(5.E-5,5.E-1), 2 =(5.E-6,5.E-2), 0 2 =(0.9,2.5)). SciPy 14 [33] implementations of both Nelder-Mead and differential evolution methods were used. 15
• Variants from the extended major histocompatibility complex (MHC) region (genome build 19 16 locations chr6:25119106-33854733) were excluded from the optimization due to the high 17 complexity of the LD structure in this region. 18
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